Key Financial Data Of Reporting Company

TOWA PHARMACEUTICAL CO.,LTD. - Filing #7297738

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
123,404,000,000 JPY
227,934,000,000 JPY
107,396,000,000 JPY
Ordinary profit (loss)
10,338,000,000 JPY
24,477,000,000 JPY
10,233,000,000 JPY
Net assets
159,110,000,000 JPY
155,893,000,000 JPY
146,861,000,000 JPY
Total assets
442,839,000,000 JPY
430,653,000,000 JPY
392,919,000,000 JPY
Basic earnings (loss) per share
133.17
328.59
141.26
Diluted earnings per share
Equity-to-asset ratio
0.359 xbrli:pure
0.362 xbrli:pure
0.374 xbrli:pure
Net cash provided by (used in) operating activities
8,654,000,000 JPY
8,212,000,000 JPY
-4,524,000,000 JPY
Net cash provided by (used in) investing activities
-12,444,000,000 JPY
-40,394,000,000 JPY
-17,814,000,000 JPY
Net cash provided by (used in) financing activities
14,203,000,000 JPY
35,407,000,000 JPY
21,129,000,000 JPY
Cash and cash equivalents
41,247,000,000 JPY
29,650,000,000 JPY
23,960,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.